glp 1 drugs and autoimmune disease GLP-1 Medications for Arthritis & Autoimmune Disease GLP-1 Drugs: For Multiple Chronic

Even with careful engineering of receptor balance, potency and pharmacokinetics, problems may still crop up, as illustrated by SAR425899s unexpected development failure due to excessive gastrointestinal adverse events during its Phase 2 trials

Or dont order a second

Hypoglycemia, or extremely low blood glucose levels, can be dangerous

Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice

The most common AEs recorded following administration of PF-06882961 were nausea, vomiting, and decreased appetite, all of which were considered treatment-related by the investigator and consistent with the expected effects of the GLP-1R agonist mechanism